Douglas B Mogul1, Xun Luo2, Mary G Bowring2, Eric K Chow2, Allan B Massie3, Kathleen B Schwarz4, Andrew M Cameron2, John F P Bridges5, Dorry L Segev3. 1. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: dmogul1@jhmi.edu. 2. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. 3. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD. 4. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD. 5. Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Abstract
OBJECTIVE: To evaluate changes in patient and graft survival for pediatric liver transplant recipients since 2002, and to determine if these outcomes vary by graft type (whole liver transplant, split liver transplant [SLT], and living donor liver transplant [LDLT]). STUDY DESIGN: We evaluated patient and graft survival among pediatric liver-only transplant recipients the PELD/MELD system was implemented using the Scientific Registry of Transplant Recipients. RESULTS: From 2002-2009 to 2010-2015, survival for SLT at 30 days improved (94% vs 98%; P < .001), and at 1 year improved for SLT (89% to 95%; P <.001) and LDLT (93% to 98%; P = .002). There was no change in survival for whole liver transplant at either 30 days (98% in both; P = .7) or 1 year (94% vs 95%; P = .2). The risk of early death with SLT was 2.14-fold higher in 2002-2009 (adjusted hazard ratio [aHR] vs whole liver transplant, 1.472.143.12), but this risk disappeared in 2010-2015 (aHR, 0.651.131.96), representing a significant improvement (P = .04). Risk of late death after SLT was similar in both time periods (aHR 2002-2009, 0.871.141.48; aHR 2010-2015, 0.560.881.37). LDLT had similar risk of early death (aHR 2002-2009, 0.491.032.14; aHR 2010-2015, 0.260.742.10) and late death (aHR 2002-2009, 0.520.831.32; aHR 2010-2015, 0.170.441.11). Graft loss was similar for SLT (aHR, 0.931.091.28) and was actually lower for LDLT (aHR, 0.530.710.95). CONCLUSIONS: In recent years, outcomes after the use of technical variant grafts are comparable with whole grafts, and may be superior for LDLT. Greater use of technical variant grafts might provide an opportunity to increase organ supply without compromising post-transplant outcomes.
OBJECTIVE: To evaluate changes in patient and graft survival for pediatric liver transplant recipients since 2002, and to determine if these outcomes vary by graft type (whole liver transplant, split liver transplant [SLT], and living donor liver transplant [LDLT]). STUDY DESIGN: We evaluated patient and graft survival among pediatric liver-only transplant recipients the PELD/MELD system was implemented using the Scientific Registry of Transplant Recipients. RESULTS: From 2002-2009 to 2010-2015, survival for SLT at 30 days improved (94% vs 98%; P < .001), and at 1 year improved for SLT (89% to 95%; P <.001) and LDLT (93% to 98%; P = .002). There was no change in survival for whole liver transplant at either 30 days (98% in both; P = .7) or 1 year (94% vs 95%; P = .2). The risk of early death with SLT was 2.14-fold higher in 2002-2009 (adjusted hazard ratio [aHR] vs whole liver transplant, 1.472.143.12), but this risk disappeared in 2010-2015 (aHR, 0.651.131.96), representing a significant improvement (P = .04). Risk of late death after SLT was similar in both time periods (aHR 2002-2009, 0.871.141.48; aHR 2010-2015, 0.560.881.37). LDLT had similar risk of early death (aHR 2002-2009, 0.491.032.14; aHR 2010-2015, 0.260.742.10) and late death (aHR 2002-2009, 0.520.831.32; aHR 2010-2015, 0.170.441.11). Graft loss was similar for SLT (aHR, 0.931.091.28) and was actually lower for LDLT (aHR, 0.530.710.95). CONCLUSIONS: In recent years, outcomes after the use of technical variant grafts are comparable with whole grafts, and may be superior for LDLT. Greater use of technical variant grafts might provide an opportunity to increase organ supply without compromising post-transplant outcomes.
Authors: Evelyn K Hsu; Michele L Shaffer; Lucy Gao; Christopher Sonnenday; Michael L Volk; John Bucuvalas; Jennifer C Lai Journal: Gastroenterology Date: 2017-07-13 Impact factor: 22.682
Authors: W R Kim; J R Lake; J M Smith; M A Skeans; D P Schladt; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2015-01 Impact factor: 8.086
Authors: D A Axelrod; N Dzebisashvili; K L Lentine; H Xiao; M Schnitzler; J E Tuttle-Newhall; D L Segev Journal: Am J Transplant Date: 2015-01 Impact factor: 8.086
Authors: Paula Buchanan; Nino Dzebisashvili; Krista L Lentine; David A Axelrod; Mark A Schnitzler; Paolo R Salvalaggio Journal: Liver Transpl Date: 2009-10 Impact factor: 5.799
Authors: Ryan P Cauley; Khashayar Vakili; Nora Fullington; Kristina Potanos; Dionne A Graham; Jonathan A Finkelstein; Heung Bae Kim Journal: J Am Coll Surg Date: 2013-08-23 Impact factor: 6.113
Authors: Douglas B Mogul; Xun Luo; Jacqueline Garonzik-Wang; Mary G Bowring; Allan B Massie; Kathleen B Schwarz; Andrew M Cameron; John F P Bridges; Dorry L Segev Journal: Liver Transpl Date: 2019-01 Impact factor: 5.799
Authors: Douglas Mogul; Emily R Perito; Nicholas Wood; George V Mazariegos; Douglas VanDerwerken; Samar H Ibrahim; Saeed Mohammad; Pamela L Valentino; Sommer Gentry; Evelyn Hsu Journal: Transplantation Date: 2019-12-27 Impact factor: 4.939
Authors: Emily R Perito; Douglas B Mogul; Douglas VanDerwerken; George Mazariegos; John Bucuvalas; Linda Book; Simon Horslen; Heung B Kim; Tamir Miloh; Vicky Ng; Jorge Reyes; Manuel I Rodriguez-Davalos; Pamela L Valentino; Sommer Gentry; Evelyn Hsu Journal: J Pediatr Gastroenterol Nutr Date: 2019-04 Impact factor: 2.839
Authors: Karina Covarrubias; Xun Luo; Allan Massie; Kathleen B Schwarz; Jacqueline Garonzik-Wang; Dorry L Segev; Douglas B Mogul Journal: Pediatr Transplant Date: 2020-03-25
Authors: Muhammad H Raza; Whitney E Jackson; Angela Dell; Li Ding; James Shapiro; Elizabeth A Pomfret; Yuri Genyk; Linda Sher; Juliet Emamaullee Journal: Am J Transplant Date: 2020-09-03 Impact factor: 8.086